17Indexed trials
mesh condition
Plaque, Amyloid
Intelligence
Plaque, Amyloid intelligence: 17 indexed trials, 4 recruiting studies, 17 sponsors across 12 countries.
4Recruiting
17Sponsors
12Countries
Leading sponsors
AC Immune SA11 recruiting
AstraZeneca10 recruiting
Emory University10 recruiting
Indiana University11 recruiting
Institute for Molecular Medicine11 recruiting
JANSSEN Alzheimer Immunotherapy Research & Development, LLC10 recruiting
Janssen Research & Development, LLC10 recruiting
Michael Rafii, MD, PhD11 recruiting
National Institute on Aging (NIA)10 recruiting
National Taiwan University Hospital10 recruiting
Novartis Pharmaceuticals10 recruiting
Sinotau Pharmaceutical Group10 recruiting
Geographic activity
United States9trials
United Kingdom4trials
Netherlands2trials
Spain2trials
Sweden2trials
Taiwan2trials
Argentina1trials
Belgium1trials
Canada1trials
China1trials
France1trials
Germany1trials
Leading interventions
Flortaucipir2trials
ACI-24.060 at Dose B in Study Part 1a1trials
ACI-24.060 with an additional adjuvant at Dose E in Study Part 1b1trials
ACI-24.060 at Dose C in Study Part 1a1trials
ACI-24.060 at Dose C in Study Part 21trials
ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b1trials
ACI-24.060 at Dose B in Study Part 21trials
AV-1959R1trials
Apolipoprotein (ApoE) detection1trials
CNP5201trials
Candesartan1trials
ACI-24.060 at Dose A in Study Part 21trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.